🇺🇸 Palliative Chemotherapy in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alanine Aminotransferase Increased — 1 report (10%)
  2. Aspartate Aminotransferase Increased — 1 report (10%)
  3. Disease Progression — 1 report (10%)
  4. Febrile Neutropenia — 1 report (10%)
  5. Immunosuppression — 1 report (10%)
  6. Leukopenia — 1 report (10%)
  7. Lymphopenia — 1 report (10%)
  8. Neutropenia — 1 report (10%)
  9. Pertussis — 1 report (10%)
  10. Pneumocystis Jiroveci Pneumonia — 1 report (10%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Palliative Chemotherapy approved in United States?

Palliative Chemotherapy does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Palliative Chemotherapy in United States?

Sun Yat-sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.